Int J Stem Cells.  2019 Mar;12(1):21-30. 10.15283/ijsc18040.

Splitomicin, a SIRT1 Inhibitor, Enhances Hematopoietic Differentiation of Mouse Embryonic Stem Cells

• Park JA
• Park S
• Park WY
• Han MK
• Lee Y

• KMID: 2447221
• DOI: http://doi.org/10.15283/ijsc18040

Abstract

BACKGROUND AND OBJECTIVES
Embryonic stem (ES) cells have pluripotent ability to differentiate into multiple tissue lineages. SIRT1 is a class III histone deacetylase which modulates chromatin remodeling, gene silencing, cell survival, metabolism, and development. In this study, we examined the effects of SIRT1 inhibitors on the hematopoietic differentiation of mouse ES cells.
METHODS AND RESULTS
Treatment with the SIRT1 inhibitors, nicotinamide and splitomicin, during the hematopoietic differentiation of ES cells enhanced the production of hematopoietic progenitors and slightly up-regulated erythroid and myeloid specific gene expression. Furthermore, treatment with splitomicin increased the percentage of erythroid and myeloid lineage cells.
CONCLUSIONS
Application of the SIRT1 inhibitor splitomicin during ES cell differentiation to hematopoietic cells enhanced the yield of specific hematopoietic lineage cells from ES cells. This result suggests that SIRT1 is involved in the regulation of hematopoietic differentiation of specific lineages and that the modulation of the SIRT1 activity can be a strategy to enhance the efficiency of hematopoietic differentiation.

Keyword

Mouse embryonic stem cells; Sirt1; Sirt1 inhibitor; Splitomicin; Hematopoietic differentiation

MeSH Terms

Animals
Cell Differentiation
Cell Survival
Chromatin Assembly and Disassembly
Gene Expression
Gene Silencing
Histone Deacetylases
Metabolism
Mice*
Mouse Embryonic Stem Cells*
Niacinamide
Histone Deacetylases
Niacinamide

Figure

• 

  Fig. 1 Schematic representation of the culture system used for hematopoietic cell differentiation from mouse ES cells. For hematopoietic EB formation, ES cells were differentiated with the methylcellulose medium with SCF for 10 days. For secondary differentiation, EBs were harvested and disrupted into single cells and replated with cytokines (SCF, IL-3, IL-6, and EPO) in the presence or absence of SIRT1 inhibitors. Counting of the colony numbers, RT-PCR and FACS analyses were performed at the indicated time points.

• 

  Fig. 2 SIRT1 inhibitors enhance hematopoietic colony forming ability during hematopoietic differentiation of mES cells. (A) Colony-forming potential of mES-derived cells in the presence of nicotinamide 0.5 mM (NAM) and splitomicin 60 μM (SP). ES cells were differentiated by EB formation for 10 days. EBs were disrupted into single cells and re-plated in 1% methylcellulose medium containing a cocktail of hematopoietic cytokines. Phase-contrast images were taken from representative BFU-E, CFU-E, CFU-GM and CFU-GEMM colonies after 7 days. Scale bar. 100 μm. (B) After the colony-forming assays, the numbers of BFU, CFU-E, CFU-GM, CFU-GEMM, and 2nd EB were scored by microscopy and compared. Each bar is expressed as the mean±standard error of the mean. *p<0.05, **p<0.01, ***p<0.001 (vs. control) of n=9 independent experiments. (C) The results are shown in percentage terms. Percentages represent the proportion of each colony type.

• 

  Fig. 3 Effects of SIRT1 inhibitors on the expression of mesodermal and hematopoietic marker genes during the hematopoietic differentiation of mES cells. (A) RNA samples were extracted on days 7, 14, and 21 during second hematopoietic differentiation, and gene expression was analyzed by RT-PCR. GAPDH is shown as a control. ES: mES cells, EB 10D: embryoid bodies obtained on day 10 of primary differentiation. Mesodermal marker, brachyury; hematopoietic stem cell and progenitor cell markers, Scl, Flk1, and HoxB4; hematopoietic lineage cell markers, GATA1 and GATA2; erythroid specific markers, βH-1 and β-major; early myeloid and lymphoid progenitor marker, Pu.1. The density of each band was measured using the ImageJ program and normalized with the density of GAPDH used as a loading control for each sample. The relative band density values were compared with the controls on day 7 (shown as fold expression). (B) RNA samples were extracted on days 7 and 14 during second hematopoietic differentiation, and gene expression was analyzed by RT-PCR. IL-7R, Rag2, and GATA3 were used as lymphoid lineage markers.

• 

  Fig. 4 Effects of SIRT1 inhibitors on the expression of hematopoietic surface antigens during hematopoietic differentiation. Expression of surface antigens was analyzed by flow cytometry. (A) Expression of CD41 and CD117 (hematopoietic progenitors), CD45 (hematopoietic), TER-119 (erythroid), CD11b (monocyte/macrophage) and Gr-1 (granulocyte) markers was monitored on day 7 of secondary hematopoietic differentiation. (B) Expression of TER-119, CD11b and Gr-1 markers was monitored on day 14 of secondary hematopoietic differentiation. EB 10D, embryoid bodies obtained on day 10 of primary differentiation. Each bar is expressed as the mean±standard error of the mean of three experiments. *p<0.05, **p<0.01 (vs. control).

Reference

References

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282:1145–1147. DOI: 10.1126/science.282.5391.1145. PMID: 9804556.

2. Boiani M, Schöler HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005; 6:872–884. DOI: 10.1038/nrm1744. PMID: 16227977.

3. Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009; 114:3513–3523. DOI: 10.1182/blood-2009-03-191304. PMID: 19652198. PMCID: 2766673.

4. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 1995; 7:862–869. DOI: 10.1016/0955-0674(95)80071-9. PMID: 8608017.

5. Keller G, Kennedy M, Papayannopoulou T, Wiles MV. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol. 1993; 13:473–486. DOI: 10.1128/MCB.13.1.473. PMID: 8417345. PMCID: 358927.

6. Yamane T, Hosen N, Yamazaki H, Weissman IL. Expression of AA4.1 marks lymphohematopoietic progenitors in early mouse development. Proc Natl Acad Sci U S A. 2009; 106:8953–8958. DOI: 10.1073/pnas.0904090106. PMID: 19458045. PMCID: 2690003.

7. Wiles MV, Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development. 1991; 111:259–267. PMID: 1893864.

8. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, Bhatia M. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood. 2003; 102:906–915. DOI: 10.1182/blood-2003-03-0832. PMID: 12702499.

9. Herrmann BG. Expression pattern of the Brachyury gene in whole-mount TWis/TWis mutant embryos. Development. 1991; 113:913–917. PMID: 1821859.

10. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995; 376:62–66. DOI: 10.1038/376062a0. PMID: 7596435.

11. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996; 86:47–57. DOI: 10.1016/S0092-8674(00)80076-8. PMID: 8689686.

12. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood. 1992; 80:575–581. PMID: 1638017.

13. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998; 12:2403–2412. DOI: 10.1101/gad.12.15.2403. PMID: 9694804. PMCID: 317050.

14. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404:1–13. DOI: 10.1042/BJ20070140. PMID: 17447894. PMCID: 2753453.

15. Sakamoto J, Miura T, Shimamoto K, Horio Y. Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett. 2004; 556:281–286. DOI: 10.1016/S0014-5793(03)01444-3. PMID: 14706864.

16. Homma K, Sone M, Taura D, Yamahara K, Suzuki Y, Takahashi K, Sonoyama T, Inuzuka M, Fukunaga Y, Tamura N, Itoh H, Yamanaka S, Nakao K. Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells. Atherosclerosis. 2010; 212:42–47. DOI: 10.1016/j.atherosclerosis.2010.04.021. PMID: 20488443.

17. Ou X, Chae HD, Wang RH, Shelley WC, Cooper S, Taylor T, Kim YJ, Deng CX, Yoder MC, Broxmeyer HE. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood. 2011; 117:440–450. DOI: 10.1182/blood-2010-03-273011. PMID: 20966168. PMCID: 3031475.

18. Berger F, Ramírez-Hernández MH, Ziegler M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci. 2004; 29:111–118. DOI: 10.1016/j.tibs.2004.01.007. PMID: 15003268.

19. Denu JM. Vitamin B3 and sirtuin function. Trends Biochem Sci. 2005; 30:479–483. DOI: 10.1016/j.tibs.2005.07.004. PMID: 16039130.

20. Giammona LM, Fuhrken PG, Papoutsakis ET, Miller WM. Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol. 2006; 135:554–566. DOI: 10.1111/j.1365-2141.2006.06341.x. PMID: 17054670.

21. Peled T, Shoham H, Aschengrau D, Yackoubov D, Frei G, Rosenheimer GN, Lerrer B, Cohen HY, Nagler A, Fibach E, Peled A. Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol. 2012; 40:342–355.e1. DOI: 10.1016/j.exphem.2011.12.005. PMID: 22198152.

22. Posakony J, Hirao M, Stevens S, Simon JA, Bedalov A. Inhibitors of Sir2: evaluation of splitomicin analogues. J Med Chem. 2004; 47:2635–2644. DOI: 10.1021/jm030473r. PMID: 15115404.

23. Neugebauer RC, Uchiechowska U, Meier R, Hruby H, Valkov V, Verdin E, Sippl W, Jung M. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. J Med Chem. 2008; 51:1203–1213. DOI: 10.1021/jm700972e. PMID: 18269226.

24. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release. Thromb Res. 2009; 124:199–207. DOI: 10.1016/j.thromres.2009.02.013. PMID: 19327818.

25. Park JA, Kim YE, Seok HJ, Park WY, Kwon HJ, Lee Y. Differentiation and upregulation of heat shock protein 70 induced by a subset of histone deacetylase inhibitors in mouse and human embryonic stem cells. BMB Rep. 2011; 44:176–181. DOI: 10.5483/BMBRep.2011.44.3.176. PMID: 21429295.

26. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 1991; 174:63–71. DOI: 10.1084/jem.174.1.63. PMID: 1711568. PMCID: 2118893.

27. Robin C, Ottersbach K, Boisset JC, Oziemlak A, Dzierzak E. CD41 is developmentally regulated and differentially expressed on mouse hematopoietic stem cells. Blood. 2011; 117:5088–5091. DOI: 10.1182/blood-2011-01-329516. PMID: 21415271. PMCID: 3109535.

28. McKinney-Freeman SL, Naveiras O, Yates F, Loewer S, Philitas M, Curran M, Park PJ, Daley GQ. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood. 2009; 114:268–278. DOI: 10.1182/blood-2008-12-193888. PMID: 19420357. PMCID: 2714203.

29. Kina T, Ikuta K, Takayama E, Wada K, Majumdar AS, Weissman IL, Katsura Y. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000; 109:280–287. DOI: 10.1046/j.1365-2141.2000.02037.x. PMID: 10848813.

30. Lai L, Alaverdi N, Maltais L, Morse HC 3rd. Mouse cell surface antigens: nomenclature and immunophenotyping. J Immunol. 1998; 160:3861–3868. PMID: 9558091.

31. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6–8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993; 151:2399–2408. PMID: 8360469.

32. Avior Y, Sagi I, Benvenisty N. Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol. 2016; 17:170–182. DOI: 10.1038/nrm.2015.27. PMID: 26818440.

33. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell. 2002; 109:29–37. DOI: 10.1016/S0092-8674(02)00680-3. PMID: 11955444.

34. Jackson M, Ma R, Taylor AH, Axton RA, Easterbrook J, Kydonaki M, Olivier E, Marenah L, Stanley EG, Elefanty AG, Mountford JC, Forrester LM. Enforced expression of HOXB4 in human embryonic stem cells enhances the production of hematopoietic progenitors but has no effect on the maturation of red blood cells. Stem Cells Transl Med. 2016; 5:981–990. DOI: 10.5966/sctm.2015-0324. PMID: 27352929. PMCID: 4954454.

35. Ding X, Lin Q, Ensenat-Waser R, Rose-John S, Zenke M. Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells. Stem Cells Dev. 2012; 21:121–132. DOI: 10.1089/scd.2010.0539. PMID: 21545235.

36. Han MK, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell. 2008; 2:241–251. DOI: 10.1016/j.stem.2008.01.002. PMID: 18371449. PMCID: 2819008.

37. Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chantada M, Martínez-Chantar ML, Embade N, López-Nieva P, Horrillo A, Hmadcha A, Soria B, Piazzolla D, Herranz D, Serrano M, Mato JM, Andrews PW, López-Larrea C, Esteller M, Fraga MF. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A. 2010; 107:13736–13741. DOI: 10.1073/pnas.1001399107. PMID: 20631301. PMCID: 2922228.

38. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010; 2:415–431. DOI: 10.18632/aging.100176. PMID: 20634564. PMCID: 2933889.

39. Matsui K, Ezoe S, Oritani K, Shibata M, Tokunaga M, Fujita N, Tanimura A, Sudo T, Tanaka H, McBurney MW, Matsumura I, Kanakura Y. NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells. Biochem Biophys Res Commun. 2012; 418:811–817. DOI: 10.1016/j.bbrc.2012.01.109. PMID: 22306819.

40. Leko V, Varnum-Finney B, Li H, Gu Y, Flowers D, Nourigat C, Bernstein ID, Bedalov A. SIRT1 is dispensable for function of hematopoietic stem cells in adult mice. Blood. 2012; 119:1856–1860. DOI: 10.1182/blood-2011-09-377077. PMID: 22219225. PMCID: 3293640.